NDC codes

409107 NDC codes with hospital pricing data in the network.

• NDC 51754600004 — GLYCOPYRROLATE PF 0.2 MG/ML IJ SOLN (61 hospitals, 2,479–2,740 samples)
• NDC 409909441 — fentaNYL 2500 mcg/50 mL Soln-IV PCA (54 hospitals, 2,314–2,737 samples)
• NDC 64253022223 — heparin porcine (PF) 10 unit/mL Syringe 3 mL SYRINGE (105 hospitals, 1,891–2,737 samples)
• NDC 00713-0351-25 — PROCHLORPERAZINE EDISYLATE 10 MG/2 ML (5 MG/ML) INJ SOLN (31 hospitals, 1,799–2,735 samples)
• NDC 00409336511 — HYDROMORPHONE 2 MG/ML INJECTION SOLUTION (153 hospitals, 889–2,734 samples)
• NDC 63323-0130-02 — DOXYCYCLINE HYCLATE 100 MG/10 ML IV (WET SOLR VIAL) (64 hospitals, 2,356–2,734 samples)
• NDC 00409131216 — HYDROmorphone 2 mg/mL injection syringe (70 hospitals, 889–2,734 samples)
• NDC 00409259605 — MIDAZOLAM 500 MG/100ML MAX CONC IV DRIP ADULT (157 hospitals, 1,329–2,733 samples)
• NDC 60505-6193-01 — PALONOSETRON 0.25 MG/5 ML INTRAVENOUS SOLUTION (134 hospitals, 2,354–2,732 samples)
• NDC 00069-0006-01 — UNCLASSIFIED DRUGS (19 hospitals, 2,093–2,732 samples)
• NDC 76045-0004-01 — MORPHINE 2 MG/ML SYRINGE SUPERORDERABLE (118 hospitals, 1,642–2,731 samples)
• NDC 00074-2051-05 — UNCLASSIFIED DRUGS (13 hospitals, 2,181–2,730 samples)
• NDC 409469954 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (35 hospitals, 2,343–2,730 samples)
• NDC 00270111103 — GADOTERIDOL 279.3 MG/ML INTRAVENOUS SOLUTION (97 hospitals, 298–2,728 samples)
• NDC 55150-0304-01 — DEXAMETHASONE SOD PHOS 10 MG/ML 1ML VIAL (61 hospitals, 2,301–2,724 samples)
• NDC 76329191201 — LABETALOL HCL 5 MG/ML IV SOLN (156 hospitals, 1,086–2,724 samples)
• NDC 71288040401 — HEPARIN SODIUM (PORCINE) 10000 UNIT/ML INJECTION S (80 hospitals, 375–2,724 samples)
• NDC 42023015901 — EPINEPHRINE 1 MG/ML (1 ML) INJECTION SOLUTION (272 hospitals, 272–2,720 samples)
• NDC 00409158750 — BUPIVACAINE HCL 0.25 % IJ SOLN (115 hospitals, 1,604–2,720 samples)
• NDC 63323-0010-20 — GENTAMICIN 40 MG/ML INJECTION SOLUTION (181 hospitals, 2,071–2,719 samples)
• NDC 69918070025 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION (140 hospitals, 1,566–2,718 samples)
• NDC 69918070026 — succinylcholine 200 mg/10 mL inj (57 hospitals, 1,566–2,718 samples)
• NDC 00641614225 — Phenylephrine Hydrochloride: 25 Vial In 1 Carton (0641-6142-25) / 1 Ml In 1 Vial (0641-6142-01) (228 hospitals, 322–2,716 samples)
• NDC 00168-0204-37 — LIDOCAINE 5 % TOPICAL OINTMENT (114 hospitals, 2,516–2,714 samples)
• NDC 00781-3317-80 — OXALIPLATIN 5 MG/ML DESENSITIZATION (62 hospitals, 2,696–2,714 samples)
• NDC 25021-0233-10 — OXALIPLATIN 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION (48 hospitals, 2,696–2,714 samples)
• NDC 00641-6195-20 — PROPOFOL INFUSION 10 MG/ML (19 hospitals, 2,254–2,713 samples)
• NDC 00338-3508-41 — CEFAZO(BAX)ISO2G/100MLPMX (86 hospitals, 2,522–2,711 samples)
• NDC 00409-4888-10 — SODIUM CHLORIDE (PF) 0.9 % IJ SOLN (135 hospitals, 1,694–2,711 samples)
• NDC 00713-0351-02 — PEGLOTICASE 8 MG/ML IV SOLN (47 hospitals, 1,685–2,711 samples)
• NDC 00409-9042-11 — BUPIVACAINE-EPINEPHRINE (PF) 0.25 %-1:200,000 INJECTION SOLUTION (22 hospitals, 2,702–2,711 samples)
• NDC 00409798309 — Sodium Chloride: 12 POUCH in 1 CASE (0409-7983-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG (91 hospitals, 848–2,711 samples)
• NDC 63323-0117-01 — FLUOROURACIL 1 GRAM/20 ML INTRAVENOUS SOLUTION (43 hospitals, 2,710 samples)
• NDC 9003928 — SOLU-MEDROL (PF) 40 MG/ML INJ SOLR (159 hospitals, 1,860–2,706 samples)
• NDC 00641602810 — fentaNYL (PF) Soln 5 mL Vial (45 hospitals, 1,409–2,705 samples)
• NDC 70092150935 — fentaNYL 2500 mcg/50 mL inj BULK (67 hospitals, 2,038–2,704 samples)
• NDC 00270141111 — IOPAMIDOL 200 MG IODINE/ML (41 %) INTRATHECAL SOLUTION (135 hospitals, 452–2,702 samples)
• NDC 63323028002 — furosemide 10 mg/mL Soln 2 mL Vial (243 hospitals, 610–2,698 samples)
• NDC 00641600801 — BUMETANIDE 0.25 MG/ML INJECTION SOLUTION (174 hospitals, 815–2,696 samples)
• NDC 31722098131 — SUCCINYLCHOLINE CHLORIDE INJ 20 MG/ML (120 hospitals, 1,553–2,696 samples)
• NDC 409427601 — lidocaine 1% inj MDV 20 mL (120 hospitals, 1,930–2,695 samples)
• NDC 00409000701 — LIDOCAINE 1% -EPINEPHRINE 1:100,000 1 %-1:100000 SOLUTION 20 ML VIAL (109 hospitals, 1,414–2,692 samples)
• NDC 00003-0893-31 — APIXABAN 2.5 MG ORAL TABLET (258 hospitals, 2,493–2,691 samples)
• NDC 00093-8180-64 — OSELTAMIV 360MG/60ML SUSP (40 hospitals, 2,399–2,687 samples)
• NDC 72611073401 — Labetalol HCl (159 hospitals, 923–2,687 samples)
• NDC 00409156019 — BUPivacaine (PF) 0.5 % (5 mg/mL) Soln 30 mL Vial (82 hospitals, 1,588–2,686 samples)
• NDC 60505623100 — CEFAZOLIN 2 GRAM SOLUTION FOR INJECTION (309 hospitals, 634–2,686 samples)
• NDC 00409316412 — MAGNESIUM SULFATE IV SOLN 40 GM/1000ML (40 MG/ML) (46 hospitals, 1,408–2,686 samples)
• NDC 00703024101 — TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJECTION (189 hospitals, 1,647–2,682 samples)
• NDC 50242008527 — ALTEPLASE 100 MG IV SOLR (438 hospitals, 746–2,681 samples)